Top news
All coverage
Kids' COVID vaccines create a new dilemma for FDA, CDC
By Caitlin Owens
Antibodies improve in quality for months after COVID-19 vaccination – Washington University School of Medicine in St ...
By Tamara Bhandari
Shingles Vaccine and COVID-19 Vaccine Timing
By Jill Seladi-Schulman
What's the difference in protection against Omicron between 2 doses and 3 doses of vaccine?
By Nathan Bartlett
Pfizer's COVID product sales to top $50 bln this year, investors want more
By Michael Erman & Manas Mishra
Latest CDC Data: Unvaccinated Adults 97 Times More Likely to Die from COVID-19 Than Boosted Adults
By Angelo Gore
Boosted? Here's how to update your COVID vaccine status on WA Verify
By Arielle Dreher
Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment
By Jared S. Hopkins & Matt Grossman
The Next Vaccine Debate: Immunize Young Children Now, or Wait? (Published 2022)
By Apoorva Mandavilli
Pfizer postpones FDA request for Covid vaccine for kids under 5
By Berkeley Lovelace & Berkeley Lovelace Jr.
Omicron and the vaccines: Your questions answered
By Bridget Balch
Five- to 11-year-old children in England to be offered Covid vaccine
By Nicola Davis, Steven Morris & Hannah Devlin
FDA delays meeting on Pfizer's COVID-19 vaccine for children under 5 to review more data
By Sarah Lynch Baldwin & Sarah Lynch
In reversal, FDA puts brakes on COVID shots for kids under 5
By Lauran Neergaard & Matthew Perrone
Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children
By Matthew Herper, Nicholas Florko & Helen Branswell
F.D.A. Delays Review of Pfizer’s Covid Vaccine for Children Under 5
By Sharon LaFraniere & Noah Mercer Weiland